Ignite Creation Date:
2025-12-24 @ 5:46 PM
Ignite Modification Date:
2026-01-22 @ 1:40 PM
Study NCT ID:
NCT04789668
Status:
COMPLETED
Last Update Posted:
2024-12-13
First Post:
2021-02-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Anatomic Stage IV Breast Cancer AJCC v8 | View |
| None | Clinical Stage IV Cutaneous Melanoma AJCC v8 | View |
| None | Hematopoietic and Lymphoid Cell Neoplasm | View |
| None | Hormone Receptor Positive Breast Adenocarcinoma | View |
| None | Metastatic Lung Non-Small Cell Carcinoma | View |
| None | Metastatic Malignant Neoplasm in the Brain | View |
| None | Metastatic Malignant Solid Neoplasm | View |
| None | Metastatic Melanoma | View |
| None | Metastatic Triple-Negative Breast Carcinoma | View |
| None | Pathologic Stage IV Cutaneous Melanoma AJCC v8 | View |
| None | Prognostic Stage IV Breast Cancer AJCC v8 | View |
| None | Stage IV Lung Cancer AJCC v8 | View |
| None | Stage IVA Lung Cancer AJCC v8 | View |
| None | Stage IVB Lung Cancer AJCC v8 | View |
Keywords: